We greatly appreciate all your hard work.

Martin

From: Johnson, Martin S. (NIH/NIAID) [E]

Sent: Friday, March 13, 2020 6:45 PM

To: Fauci, Anthony (NIH/NIAID) EC) >; Auchincloss, Hugh (NIH/NIAID) (E]
CY >; NIAID OCGR Leg <NIAIDOCGRLeg@mail.nih.gov>; McGowan, John J.
(NIH/NIAID) [E] >: Harper, Jill (NIH/NIAID) (EID);
Crum, Wayne (NIH/NIAID) [E) {© G}>; Erbelding, Emily (NIH/NIAID) [E]
Cc O>

Ce: Eisinger, Robert (NIH/NIAID) (EJE___ (0) >; Folkers, Greg (NIH/NIAID) [E]
=>; Conrad, Patricia (NIH/NIAID) (EJZ 8) J; Marston,
Hilary (NIH/NIAID) [E)fE——————_) 6)>; Lerner, Andrea (NIH/NIAID) [E]
CO J>; Doepel, Laurie (NIH/NIAID) (EJ) >; Gilles, Sharon
(NIH/NIAID) [E] [OF >; Routh, Jennifer (NIH/NIAID) [E] [OY >;
Stover, Kathy (NIH/NIAID) (E] [—________ ©) @}>; Law, Kim (NIH/NIAID) [E] L____ ©) >;
Lee, Kun-Lin (NIH/NIAID) [E] [@) 6}; Bushar, Nicholas (NIH/NIAID) (E]
CC >; Schneider, Johanna (NIH/NIAID) [E] (oO GF

Subject: RE: FY 2020 - COVID-19 - Actual and Forecasted Spending - Weekly Report Ending 3 "12/20
Tony,

Since we our last report we have increased spending on the COVID-19 response by $1.5M fora
total YTD spending of $14.1M.

The $1.5M increase is for the following:

$1.0M awarded to set-up clinical sites at Emory and U. Washington Seattle for adaptable
RCT of remdesivir.
